Growth Metrics

Volitionrx (VNRX) Cash from Investing Activities Growth (1y) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn 94.46%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 94.46%
Jun 30, 2025 52.14%
Mar 31, 2025 97.71%
Dec 31, 2024 35.91%
Sep 30, 2024 49.92%
Jun 30, 2024 46.77%
Mar 31, 2024 60.71%
Dec 31, 2023 46.66%
Sep 30, 2023 16.11%
Jun 30, 2023 44.32%
Mar 31, 2023 -60.93%
Dec 31, 2022 -350.14%
Sep 30, 2022 -129.53%
Jun 30, 2022 -146.90%
Mar 31, 2022 74.24%
Dec 31, 2021 87.93%
Sep 30, 2021 -1,047.15%
Jun 30, 2021 17.79%
Mar 31, 2021 -46.34%
Dec 31, 2020 -601.98%
Sep 30, 2020 112.21%
Jun 30, 2020 -113.80%
Mar 31, 2020 -194.99%
Dec 31, 2019 -28.33%
Sep 30, 2019 -111.40%
Jun 30, 2019 -92.32%
Mar 31, 2019 -84.81%
Dec 31, 2018 -39.16%
Sep 30, 2018 44.91%
Jun 30, 2018 81.98%
Mar 31, 2018 93.07%
Dec 31, 2017 73.90%
Sep 30, 2017 -400.39%
Dec 31, 2016 -3,399.07%
Sep 30, 2016 -273.18%
Dec 31, 2015 -72.93%
Sep 30, 2015 97.75%
Jun 30, 2015 -53.63%
Mar 31, 2015 -305.72%
Dec 31, 2014 -538,100.00%
Sep 30, 2014 -25,093,700.00%
Mar 31, 2014 -2,430.39%
Dec 31, 2013 99.99%
Sep 30, 2013 100.22%
Mar 31, 2013 98.11%
Dec 31, 2012 -84.82%
Sep 30, 2012 97.75%
Jun 30, 2012 -681.73%